Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Levy

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Relevance of different results of different anti-double-stranded DNA assays in reporting clinical studies: comment on the article by Petri et al. ReplyMichelle A Petri, Ronald F van Vollenhoven, Jill Buyon, et al.
Clinical and Experimental Rheumatology|October 30, 2020
The association between active proliferative lupus nephritis during pregnancy and small for gestational age newbornsMarcela Ignacchiti Lacerda, Bruna Costa Rodrigues, Guilherme Ramires de Jesús, et al.
The Israel Medical Association Journal : IMAJ|February 12, 2013
Pregnancy may aggravate arterial hypertension in women with Takayasu arteritisGuilherme R de Jesús, Isabelle C C d'Oliveira, Flávia Cunha dos Santos, et al.
RMD Open|July 3, 2026
Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trialsIoannis Parodis, Julius Lindblom, Roger A Levy, et al.
Lupus Science & Medicine|August 3, 2023
Lupus spectrum ambiguity has long-term negative implications for patientsIan N Bruce, Joy Buie, Lauren Bloch, et al.
Arthritis Research & Therapy|May 6, 2020
The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysisChristel Wilkinson, Robert B Henderson, Angela R Jones-Leone, et al.
Revista Brasileira De Reumatologia|July 17, 2013
Guidelines for the treatment of antiphospholipid syndromeAdriana Danowski, Jozelia Rego, Adriana M Kakehasi, et al.
Lupus Science & Medicine|May 5, 2023
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeksBinod Neupane, Pragya Shukla, Mahmoud Slim, et al.
Thrombosis and Haemostasis|October 1, 2015
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgmentSavino Sciascia, D Ware Branch, Roger A Levy, et al.
Lupus Science & Medicine|November 28, 2024
Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus CohortMurray Urowitz, Mary E Georgiou, Zahi Touma, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Arthritis & Rheumatology (Hoboken, N.J.)|February 8, 2014
Relevance of different results of different anti-double-stranded DNA assays in reporting clinical studies: comment on the article by Petri et al. ReplyMichelle A Petri, Ronald F van Vollenhoven, Jill Buyon, et al.
Clinical and Experimental Rheumatology|October 30, 2020
The association between active proliferative lupus nephritis during pregnancy and small for gestational age newbornsMarcela Ignacchiti Lacerda, Bruna Costa Rodrigues, Guilherme Ramires de Jesús, et al.
The Israel Medical Association Journal : IMAJ|February 12, 2013
Pregnancy may aggravate arterial hypertension in women with Takayasu arteritisGuilherme R de Jesús, Isabelle C C d'Oliveira, Flávia Cunha dos Santos, et al.
RMD Open|July 3, 2026
Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trialsIoannis Parodis, Julius Lindblom, Roger A Levy, et al.
Lupus Science & Medicine|August 3, 2023
Lupus spectrum ambiguity has long-term negative implications for patientsIan N Bruce, Joy Buie, Lauren Bloch, et al.
Arthritis Research & Therapy|May 6, 2020
The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysisChristel Wilkinson, Robert B Henderson, Angela R Jones-Leone, et al.
Revista Brasileira De Reumatologia|July 17, 2013
Guidelines for the treatment of antiphospholipid syndromeAdriana Danowski, Jozelia Rego, Adriana M Kakehasi, et al.
Lupus Science & Medicine|May 5, 2023
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeksBinod Neupane, Pragya Shukla, Mahmoud Slim, et al.
Thrombosis and Haemostasis|October 1, 2015
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgmentSavino Sciascia, D Ware Branch, Roger A Levy, et al.
Lupus Science & Medicine|November 28, 2024
Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus CohortMurray Urowitz, Mary E Georgiou, Zahi Touma, et al.
Pageof 8